Che, H.
Breuil, V.
Cortet, B.
Paccou, J.
Thomas, T.
Chapuis, L.
Debiais, F.
Mehsen-Cetre, N.
Javier, R.M.
Loiseau Peres, S.
Roux, C.
Briot, K.
Article History
Received: 28 May 2018
Accepted: 29 November 2018
First Online: 5 December 2018
Compliance with ethical standards
:
: Dr. Breuil received grant support and lecture fees from Amgen, Novartis, Chugai, and Lilly. Dr. Briot has received research grants or honoraria from Amgen, Lilly, Medtronic, and MSD. Dr. Cortet has received research grants or honoraria from Amgen, Expanscience, Ferring, Lilly, Medtronic, MSD, Mylan, Novartis, Roche diagnostics, Théramex, and UCB. Dr. Thomas received grant support, lecture fees, and consulting fees from Amgen, Merck Sharp & Dohme, and UCB Pharma; grant support and lecture fees from Chugai and Pfizer; consulting fees from Expanscience, Gilead Sciences, LCA, Thuasne, and Medac; grant support and consulting fees from HAC Pharma; grant support from Novartis; lecture fees from AbbVie, Biogen, and Bristol-Myers Squibb; and lecture fees and consulting fees from Eli Lilly and Teva Pharmaceutical Industries. Dr. Roux has received grants and/or honoraria from Alexion, Amgen, MSD, UCB. Dr. Che, Dr. Paccou, Dr. Chapuis, Dr. Debiais, Dr. Mehsen-Cetre, Dr. Javier, and Dr. Loiseau Peres have no disclosure to declare.